Stockreport

Study shows Nu.Q® Lung Cancer Test differentiated malignant and benign nodules found by Low Dose CT screening [Yahoo! Finance]

VolitionRX Limited  (VNRX) 
NASDAQ:AMEX Investor Relations: ir.volitionrx.com
PDF announced the results of a large-scale study which shows that its Nu.Q ® Cancer Test differentiated between malignant and benign pulmonary nodules, found by Low Dose CT [Read more]